| Patent Number | Grant Date | Title | Applicant |
|---|---|---|---|
| EP3035951 | Sep 4, 2024 | Beta-Casein A2 And Blood Glucose Levels | THE A2 MILK COMPANY LIMITED |
| EP2736487 | Aug 28, 2024 | New (Trimethoxyphenylamino)Pyrimidinyl Formulations | RIGEL PHARMACEUTICALS, INC. |
| EP3076983 | Aug 14, 2024 | Ionic Aqueous Compositions | GEROLYMATOS INTERNATIONAL S.A. |
| EP3102208 | Jul 17, 2024 | Crystalline Polymorphs Of The Free Base Of 2-Hydroxy-6-((2-(1-Isopropyl-1H-Pyrazol-5-Yl)Pyridin-3-Yl)Methoxy)Benzaldehyde | GLOBAL BLOOD THERAPEUTICS, INC. |
| EP2104490 | Jun 26, 2024 | Micronised Particles Of Low-Dosage Strength Active Agents For Powder Formulations For Inhalation | CHIESI FARMACEUTICI S.P.A. |
| EP2464337 | Jun 26, 2024 | Pharmaceutical Composition And Administrations Thereof | VERTEX PHARMACEUTICALS INC. |
| EP3578169 | Jun 26, 2024 | Pharmaceutical Formulations Comprising 4-{(1 R)-2-[(6-{2-[(2,6-Dichlorobenzyl)Oxy]Ethoxy}Hexyl)Amino]-1-Hydroxyethyl}-2-(Hydroxymethyl)Phenol | GLAXO GROUP LIMITED |
| EP1962797 | May 29, 2024 | Powder Compositions For Inhalation | JAGOTEC AG |
| EP3256569 | Apr 17, 2024 | Alveolar-Like Macrophages And Method Of Generating Same | THE HOSPITAL FOR SICK CHILDREN |
| EP4084799 | Apr 17, 2024 | Use Of Nmn For The Prevention And/Or Treatment Of Joint Pain Induced By Physical Activity, And Corresponding Compositions | NUVAMID SA |
| Patent Number | Grant Date | Title | Applicant | Facing Oppositions |
|---|---|---|---|---|
| EP3725778 | Aug 18, 2021 | Formulations Of Enzalutamide | ASTELLAS PHARMA INC. | 88 |
| EP2478907 | Apr 14, 2021 | Methods And Compositions For Treating Cancer | COUGAR BIOTECHNOLOGY, INC. | 44 |
| EP2397142 | Jul 27, 2022 | Use Of Dpp Iv Inhibitors | BOEHRINGER INGELHEIM INTERNATIONAL GMBH | 40 |
| EP3293202 | Feb 7, 2024 | Anti Human Interleukin 1 Receptor Accessory Protein (Il1rap) Antibodies And Uses Thereof | CANTARGIA AB | 36 |
| EP3621596 | Feb 23, 2022 | Nucleic Acid Vector Tablets | ECOLE NATIONALE SUPÉRIEURE D'ARTS ET MÉTIERS | 24 |
| EP3204047 | May 27, 2020 | Calcifediol Soft Capsules | FAES FARMA, S.A. | 21 |
| EP2228064 | Dec 11, 2019 | Pharmaceutical Composition Containing Glycopyrrolate And A Beta2 Adrenoceptor Agonist | NOVARTIS PHARMA GMBH | 20 |
| EP2968155 | Mar 3, 2021 | Tofacitinib Oral Sustained Release Dosage Forms | PFIZER INC. | 18 |
| EP2968172 | Oct 7, 2020 | Stabilized Modified Release Vitamin D Formulation And Method Of Administring Same | OPKO IRELAND GLOBAL HOLDINGS, LIMITED | 18 |
| EP2637664 | Mar 29, 2017 | Compositions And Methods Of Treating Pulmonary Hypertension | GILEAD SCIENCES, INC. | 18 |
Feel free to send us a message here and we will get back to you